New real-world and implementation study data highlight the efficacy of ViiV’s long-acting injectables for HIV prevention and ...
Switching to long-acting ART from oral treatments was cost effective for postpartum women with HIV and improved infant outcomes, researchers said at the Conference on Retroviruses and Opportunistic ...
Promising results from an early-stage trial suggest that lenacapavir injections might offer long-lasting protection.
Montgomery Advertiser on MSN14h
Alabama still fighting HIV: 'In the South is where we have the majority of the problems':Nearly half of all new cases in 2022 were in the South. "The frustrating part is we have the tools now to stop it." ...
Like most prescribed medications, all three brands PrEP brands feature side effects. Here's how to prepare for them.
But turning this crisis into an opportunity is possible. To mitigate the effects of the funding freeze, Bekker said swift ...
Human rights, key and vulnerable populations Ethiopia received PEPFAR funding for work on stigma, discrimination and enabling legal environments. As a result of the USG stop-work order, all programmes ...
To manage risk, investors should diversify their stock portfolio across industries and this could be the stock to study in the pharmaceutical sector for the long haul.
Ministry of Health Flags Off Critical Human Immunodeficiency Virus (HIV) Commodities at Mission for Essential Drugs and Supplies (MEDS) ...
The commodities, which were flagged off by Health Cabinet Secretary Deborah Barasa on Friday, March 14, include ARV drugs ...
The collection of public health surveillance data has always reflected ideas about individual rights.
Other bills in Springfield would put limits on AI for health insurers and establish coverage for Alzheimer's testing.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback